Literature DB >> 19925394

Targeting prostate cancer stem cells.

Francesco Crea1, Lesley A Mathews, William L Farrar, Elaine M Hurt.   

Abstract

Cancer stem cells are the sub-population of cells present within tumors responsible for tumorigenesis. These cells have unique biological properties including self-renewal and the ability to differentiate. Furthermore, it is thought that these cells are more resistant to conventional chemotherapy and, as a result, are responsible for patient relapse. We will discuss the identification of prostate cancer stem cells, their unique properties and how these cells may be targeted for more efficacious therapies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19925394     DOI: 10.2174/187152009789735053

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  10 in total

1.  Cancer complementary and alternative medicine research at the US National Cancer Institute.

Authors:  Libin Jia
Journal:  Chin J Integr Med       Date:  2012-01-12       Impact factor: 1.978

Review 2.  The cancer stem cell niche--there goes the neighborhood?

Authors:  Stephanie M Cabarcas; Lesley A Mathews; William L Farrar
Journal:  Int J Cancer       Date:  2011-09-14       Impact factor: 7.396

Review 3.  Pharmacogenomics and cancer stem cells: a changing landscape?

Authors:  Francesco Crea; Maria Ana Duhagon; William L Farrar; Romano Danesi
Journal:  Trends Pharmacol Sci       Date:  2011-04-27       Impact factor: 14.819

4.  A 1536-well quantitative high-throughput screen to identify compounds targeting cancer stem cells.

Authors:  Lesley A Mathews; Jonathan M Keller; Bonnie L Goodwin; Rajarshi Guha; Paul Shinn; Rebecca Mull; Craig J Thomas; Rachel L de Kluyver; Thomas J Sayers; Marc Ferrer
Journal:  J Biomol Screen       Date:  2012-08-27

5.  Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer.

Authors:  Francesco Crea; Elaine M Hurt; Lesley A Mathews; Stephanie M Cabarcas; Lei Sun; Victor E Marquez; Romano Danesi; William L Farrar
Journal:  Mol Cancer       Date:  2011-04-18       Impact factor: 27.401

6.  Prostate cancer cell lines under hypoxia exhibit greater stem-like properties.

Authors:  Yuanyuan Ma; Dongming Liang; Jian Liu; Karol Axcrona; Gunnar Kvalheim; Trond Stokke; Jahn M Nesland; Zhenhe Suo
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

7.  From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?

Authors:  Katarzyna Szarc vel Szic; Ken Declerck; Melita Vidaković; Wim Vanden Berghe
Journal:  Clin Epigenetics       Date:  2015-03-25       Impact factor: 6.551

8.  [Isolation and identification of CD133 positive and negative cells from human lung cancer and screening of the differential genes between the positive and negative cells].

Authors:  Shaoqiu Zheng; Shuhua Li; Hongyan Wang; Xiaobin Xie; Yajie Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-03

9.  Inhibition of 5-lipoxygenase downregulates stemness and kills prostate cancer stem cells by triggering apoptosis via activation of c-Jun N-terminal kinase.

Authors:  Sivalokanathan Sarveswaran; Nadimpalli R S Varma; Shravan Morisetty; Jagadananda Ghosh
Journal:  Oncotarget       Date:  2019-01-11

10.  Update of research on the role of EZH2 in cancer progression.

Authors:  Liang Shen; Jing Cui; Shumei Liang; Yingxin Pang; Peishu Liu
Journal:  Onco Targets Ther       Date:  2013-04-04       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.